Cerianna™: Seeing Deeper into Recurrent or Metastatic Breast Cancer

Featured Video Play Icon

During this webinar, Dr. Mazzarelli’s presentation will review the unmet imaging needs in recurrent and metastatic breast cancer, estrogen receptor heterogeneity in metastatic breast cancer, and the acquisition and interpretation of Cerianna. He will also review cases that demonstrate how determining full-body ER + lesions status may impact patient care.

Next Post

Illumina and Deerfield Management partner to accelerate drug development

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, and Deerfield Management, a healthcare investment management firm, today announced a five-year partnership to apply a genetic-led approach to the discovery and development of novel therapies for diseases with unmet medical needs. The partnership aims to leverage genomic tools […]